BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 19410162)

  • 1. Identification and treatment of prediabetes to prevent progression to type 2 diabetes.
    Fonseca VA
    Clin Cornerstone; 2008; 9(2):51-9; discussion 60-1. PubMed ID: 19410162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and treatment of prediabetes to prevent progression to type 2 diabetes.
    Fonseca VA
    Clin Cornerstone; 2007; 8(2):10-8; discussion 19-20. PubMed ID: 18357952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug therapy in prediabetes.
    Mukhopadhyay P; Chowdhury S
    J Indian Med Assoc; 2005 Nov; 103(11):603-5, 608. PubMed ID: 16570765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological strategies for preventing type 2 diabetes in patients with impaired glucose tolerance.
    Smith-Marsh D
    Drugs Today (Barc); 2013 Aug; 49(8):499-507. PubMed ID: 23977667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What are the pharmacotherapy options for treating prediabetes?
    Daniele G; Abdul-Ghani M; DeFronzo RA
    Expert Opin Pharmacother; 2014 Oct; 15(14):2003-18. PubMed ID: 25139488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reflecting on type 2 diabetes prevention: more questions than answers!
    Rosenstock J
    Diabetes Obes Metab; 2007 Sep; 9 Suppl 1():3-11. PubMed ID: 17877541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Steps toward the primary prevention of type II diabetes mellitus. Various epidemiological considerations].
    Flórez H
    Invest Clin; 1997 Mar; 38(1):39-52. PubMed ID: 9235072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Inquiries: How can we keep impaired glucose tolerance and impaired fasting glucose from progressing to diabetes?
    Swanson A; Watrin K; Wilder L
    J Fam Pract; 2010 Sep; 59(9):532-3. PubMed ID: 20824232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic prevention or delay of type 2 diabetes mellitus.
    Anderson DC
    Ann Pharmacother; 2005 Jan; 39(1):102-9. PubMed ID: 15562143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of prediabetes in clinical practice: targeting insulin resistance and β-cell dysfunction.
    Armato J; DeFronzo RA; Abdul-Ghani M; Ruby R
    Endocr Pract; 2012; 18(3):342-50. PubMed ID: 22068250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of type 2 diabetes in the prediabetic population.
    Maji D; Roy RU; Das S
    J Indian Med Assoc; 2005 Nov; 103(11):609-11. PubMed ID: 16570766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Progress in the prevention of type 2 diabetes].
    Schernthaner G
    Wien Klin Wochenschr; 2003 Nov; 115(21-22):745-57. PubMed ID: 14743578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Use of Metformin in Prediabetes and Diabetes Prevention.
    Hostalek U; Gwilt M; Hildemann S
    Drugs; 2015 Jul; 75(10):1071-94. PubMed ID: 26059289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired glucose tolerance and impaired fasting glucose--a review of diagnosis, clinical implications and management.
    Petersen JL; McGuire DK
    Diab Vasc Dis Res; 2005 Feb; 2(1):9-15. PubMed ID: 16305067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delaying the onset of type 2 diabetes mellitus in patients with prediabetes.
    Irons BK; Mazzolini TA; Greene RS
    Pharmacotherapy; 2004 Mar; 24(3):362-71. PubMed ID: 15040650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Is type-2 diabetes mellitus preventable?].
    Jermendy G
    Orv Hetil; 2003 Sep; 144(39):1909-17. PubMed ID: 14598569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular benefits and safety profile of acarbose therapy in prediabetes and established type 2 diabetes.
    Hanefeld M
    Cardiovasc Diabetol; 2007 Aug; 6():20. PubMed ID: 17697384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic treatment options for prediabetes.
    Hsueh WA; Handelsman Y
    Nat Clin Pract Endocrinol Metab; 2008 Jul; 4(7):380-1. PubMed ID: 18523427
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of lifestyle interventions with or without metformin therapy on serum levels of osteoprotegerin and receptor activator of nuclear factor kappa B ligand in patients with prediabetes.
    Arslan MS; Tutal E; Sahin M; Karakose M; Ucan B; Ozturk G; Cakal E; Biyikli Gencturk Z; Ozbek M; Delibasi T
    Endocrine; 2017 Feb; 55(2):410-415. PubMed ID: 27743302
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.